These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12917444)

  • 1. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons.
    Roucou X; Guo Q; Zhang Y; Goodyer CG; LeBlanc AC
    J Biol Chem; 2003 Oct; 278(42):40877-81. PubMed ID: 12917444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations.
    Fioriti L; Dossena S; Stewart LR; Stewart RS; Harris DA; Forloni G; Chiesa R
    J Biol Chem; 2005 Mar; 280(12):11320-8. PubMed ID: 15632159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic prion protein is the predominant anti-Bax prion protein form: exclusion of transmembrane and secreted prion protein forms in the anti-Bax function.
    Lin DT; Jodoin J; Baril M; Goodyer CG; Leblanc AC
    Biochim Biophys Acta; 2008 Oct; 1783(10):2001-12. PubMed ID: 18590778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian prion protein suppresses Bax-induced cell death in yeast.
    Li A; Harris DA
    J Biol Chem; 2005 Apr; 280(17):17430-4. PubMed ID: 15753097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion protein protects human neurons against Bax-mediated apoptosis.
    Bounhar Y; Zhang Y; Goodyer CG; LeBlanc A
    J Biol Chem; 2001 Oct; 276(42):39145-9. PubMed ID: 11522774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal globular domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum.
    Heske J; Heller U; Winklhofer KF; Tatzelt J
    J Biol Chem; 2004 Feb; 279(7):5435-43. PubMed ID: 14645231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol.
    Wang X; Wang F; Sy MS; Ma J
    J Biol Chem; 2005 Jan; 280(1):317-25. PubMed ID: 15525638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
    Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.
    Ma J; Wollmann R; Lindquist S
    Science; 2002 Nov; 298(5599):1781-5. PubMed ID: 12386337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosolic prion protein toxicity is independent of cellular prion protein expression and prion propagation.
    Norstrom EM; Ciaccio MF; Rassbach B; Wollmann R; Mastrianni JA
    J Virol; 2007 Mar; 81(6):2831-7. PubMed ID: 17182694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reticulon 3 attenuates the clearance of cytosolic prion aggregates via inhibiting autophagy.
    Chen R; Jin R; Wu L; Ye X; Yang Y; Luo K; Wang W; Wu D; Ye X; Huang L; Huang T; Xiao G
    Autophagy; 2011 Feb; 7(2):205-16. PubMed ID: 21119307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein misfolding cyclic amplification induces the conversion of recombinant prion protein to PrP oligomers causing neuronal apoptosis.
    Yuan Z; Yang L; Chen B; Zhu T; Hassan MF; Yin X; Zhou X; Zhao D
    J Neurochem; 2015 Jun; 133(5):722-9. PubMed ID: 25810062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation.
    Drisaldi B; Stewart RS; Adles C; Stewart LR; Quaglio E; Biasini E; Fioriti L; Chiesa R; Harris DA
    J Biol Chem; 2003 Jun; 278(24):21732-43. PubMed ID: 12663673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial prion protein mutants inhibit Hrd1-mediated retrotranslocation of misfolded proteins by depleting misfolded protein sensor BiP.
    Peters SL; Déry MA; LeBlanc AC
    Hum Mol Genet; 2016 Mar; 25(5):976-88. PubMed ID: 26740554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Prn-p gene and stable transfection of Prn-p cDNA in leukemia MEL and neuroblastoma N2a cells increased production of PrP(C) but not prevented DNA fragmentation initiated by serum deprivation.
    Gougoumas DD; Vizirianakis IS; Triviai IN; Tsiftsoglou AS
    J Cell Physiol; 2007 May; 211(2):551-9. PubMed ID: 17186498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective retrotranslocation causes loss of anti-Bax function in human familial prion protein mutants.
    Jodoin J; Laroche-Pierre S; Goodyer CG; LeBlanc AC
    J Neurosci; 2007 May; 27(19):5081-91. PubMed ID: 17494694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection.
    Stewart RS; Harris DA
    J Biol Chem; 2003 Nov; 278(46):45960-8. PubMed ID: 12933795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells.
    Dron M; Dandoy-Dron F; Farooq Salamat MK; Laude H
    J Gen Virol; 2009 Aug; 90(Pt 8):2050-2060. PubMed ID: 19339478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 70 selectively mediates the degradation of cytosolic PrPs and restores the cytosolic PrP-induced cytotoxicity via a molecular interaction.
    Zhang J; Wang K; Guo Y; Shi Q; Tian C; Chen C; Gao C; Zhang BY; Dong XP
    Virol J; 2012 Dec; 9():303. PubMed ID: 23216755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mutant or cytosolic PrP in transgenic mice and cells is not associated with endoplasmic reticulum stress or proteasome dysfunction.
    Quaglio E; Restelli E; Garofoli A; Dossena S; De Luigi A; Tagliavacca L; Imperiale D; Migheli A; Salmona M; Sitia R; Forloni G; Chiesa R
    PLoS One; 2011 Apr; 6(4):e19339. PubMed ID: 21559407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.